Reduction of salivary flow with scopoderm tts

Yoav P. Talmi*, Yuval Zohar, Yehuda Finkelstein, Nelu Laurian

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Scopoderm transdermal therapeutic system (TTS) is a form of application permitting programmed release of scopolamine through the skin into the bloodstream. Scopoderm TTS is indicated for prevention of nausea and vomiting associated with motion sickness. The most common side effect associated with its use is dryness of the mouth. We have been using Scopoderm TTS for reducing salivary flow in patients with sialorrhea or with difficulties in swallowing normal amounts of salivary secretions. Good results were achieved with minimal discomfort from adverse effects. We recommend the use of Scopoderm TTS in selected cases of sialorrhea and drooling, preoperatively and postoperatively in patients undergoing surgery of oral, laryngeal, and pharyngeal lesions.

Original languageEnglish
Pages (from-to)128-130
Number of pages3
JournalAnnals of Otology, Rhinology and Laryngology
Volume97
Issue number2
DOIs
StatePublished - Mar 1988
Externally publishedYes

Keywords

  • Scopoderm TTS
  • salivation
  • scopolamine
  • sialorrhea

Fingerprint

Dive into the research topics of 'Reduction of salivary flow with scopoderm tts'. Together they form a unique fingerprint.

Cite this